Biobanking Market Trend, Analysis, Strategic Assessment, Trend Outlook and Business Opportunities 2022-2030
Biobanking Market Size – USD 29.79 Billion in 2020, Market Growth – at a CAGR of 8.6%
VANCOUER, BC, CANADA, April 13, 2022 /EINPresswire.com/ -- The report delivers a methodical study of the Biobanking Market fragments and an extensive analysis of the market overview. A thoughtful assessment of the recent market trends as well as the future prospects are offered in the report. It further shares an exhaustive analysis of the regional insights and their role in shaping the market growth. The COVID-19 impacts have been recently mentioned in the report to aid business professionals to recognize the risks in a better manner. It focuses on the vital players and their significant strategies to remain in the principal position.
The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period, according to latest analysis by Emergen Research. Increasing genomic research activities and investment in R&D by major companies is driving global biobanking market revenue growth. Surge in research activities of regenerative medicines, stem cell therapeutics, and cell and gene therapy is also driving revenue growth of the global market.
DOWNLOAD FREE SAMPLE REPORT @ https://www.emergenresearch.com/request-sample/926
Biobanking market revenue growth is also driven by increase in application of bio-banked samples. Biobanks focusing on plants, animals, and microbes are evolving rapidly. Different types of biobanks are gaining traction, such as disease-centric biobanks, population-based banks, DNA/RNA banks, genetic banks, tissue banks, blood banks, virtual biobanks, stem cell banks, microbiome banks, and others, which is driving market revenue growth.
Key players in the market K. Biobank Limited, Medizinische Universitat Graz, Hamilton Company, ASKION, Azenta Life Sciences, Qiagen, Promega Corporation, Integrated Biobank of Luxembourg (IBBL), Isenet Biobanking, and Thermo Fisher Scientific, Inc.
Some Key Highlights from the Report
Blood product segment registered a significantly robust revenue growth rate in 2020. Blood is among the most common biospecimens collected in human biobanks as it is a source of RNA and DNA. Blood is a widely used biospecimen as it carries the potential to search for biomarkers in various diseases, which make standardization and optimization of blood collection procedures of high importance.
Among the application segments, the regenerative medicine segment accounted for significantly large revenue share in 2020. Increasing demand for qualitative bio samples and increasing research in regenerative medicine is driving revenue growth of this segment. Additionally, research programs designed to increase R&D in sustainable medicine is expected to continue to support revenue growth of this segment.
Market in Asia Pacific is expected to register a rapid revenue growth rate during the forecast period owing to improvements in lifescience research infrastructure and rising government investment in the fields of biotechnology, pharmaceuticals, and biomedicals. Increasing global population and expansion of biobanks in China, Japan, South Korea, Singapore, Australia, and India is contributing significantly to market revenue growth.
To identify the key trends in the industry, click on the link below: @ https://www.emergenresearch.com/industry-report/biobanking-market
Key questions answered in the report:
What is the growth potential of the Biobanking Market ?
Which regional Biobanking Market will emerge as a forerunner in the coming years?
Which application segment will grow at a steady pace?
What are the growth opportunities that could emerge as top industry players in the coming years?
What are the main challenges that the global Biobanking Market could face in the future?
What are the leading companies in the world market of Biobanking Market ?
What are the main trends that have a positive impact on the growth of the Biobanking Market ?
Emergen Research has segmented the global Biobanking Market Are :
Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:
Biobanking Market Product & Services Outlook (Revenue, USD Billion; 2018–2030)
Equipment
Storage Equipment
Sample Transport Equipment
Sample Processing Equipment
Sample Analysis Equipment
Consumables
Collection Consumables
Storage Consumables
Processing Consumables
Analysis Consumables
Services
Supply Services
Processing Services
Storage Services
Transport Services
Software
Biobanking Market Sample Type Outlook (Revenue, USD Billion; 2018–2030)
Biological Fluids
Human Tissues
Blood Products
Nucleic Acids
Human Waste Products
Cell Lines
Storage Type Outlook (Revenue, USD Billion; 2018–2030)
Automated Storage
Manual Storage
Geographic Segment Covered in the Report:
The Biobanking Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
North America (USA and Canada)
Europe (UK, Germany, France and the rest of Europe)
Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
Latin America (Brazil, Mexico, and the rest of Latin America)
Middle East and Africa (GCC and rest of the Middle East and Africa)
Direct Purchase Report @ https://www.emergenresearch.com/select-license/926
Highlights of the TOC:
Report Overview
1 Research Scope
2 Key Biobanking Market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline
Global Growth Trends
1 Global Biobanking Market size
2 Latest Biobanking Market trends
2.3 Key growth trends
Competitive Landscape
1 Global Biobanking Market key players
2 Global Biobanking Market size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Biobanking Market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
Find similar reports by emergen research @
Whole Exome Sequencing Market https://www.emergenresearch.com/industry-report/whole-exome-sequencing-market
Phospholipids Market https://www.emergenresearch.com/industry-report/phospholipids-market
Culture Media Market https://www.emergenresearch.com/industry-report/culture-media-market
Leadless Pacemaker Systems Market https://www.emergenresearch.com/industry-report/leadless-pacemaker-systems-market
Biobanking Market https://www.emergenresearch.com/industry-report/biobanking-market
About us:
Emergen research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Thank you for reading our report. Customization of the report is available according to the requirements of clients. Kindly get in touch with us to know more about the report.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.